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Abstract
The Framingham Heart Study provides a unique source of longitudinal family data related to CVD
risk factors. Age-stratified heritability estimates were obtained over three age groups (31–49 years,
50–60 years, and 61–79 years), reflecting the longitudinal nature of the data, for four quantitative
traits. Age-adjusted heritability estimates were obtained at a single common time point for the
same four quantitative traits. The importance of these groups is that they consist of the same
individuals. The highest age-stratified heritability estimate (h2 = 0.88 (± 0.06)) was for height in the
model adjusting for gender over all three age groups. SBP gave the lowest heritability estimate (h2
= 0.15 (± 0.11)) for the 70 age group in the model adjusting for gender, height, BMI, smoker, and
drinker. BMI had slightly higher estimates (h2 = 0.64 (± 0.11)) in the 40 age group than previously
published. The highest age-adjusted heritability estimate (h2 = 0.90 (± 0.06)) was for height in the
model adjusting for gender. SBP gave the lowest heritability estimate (h2 = 0.38 (± 0.09)) for
unadjusted model. These results indicate that some common, complex traits may vary little in their
genetic architecture over time and suggest that a common set of genes may be contributing to
observed variation for these longitudinally collected phenotypes.
Background
Cardiovascular disease (CVD) has a complex genetic
basis. There are major risk factors that cannot be changed-
heredity, gender, and increasing age. Many risk factors can
be changed — obesity, high blood pressure, smoking,
high cholesterol levels, physical inactivity, stress, and sub-
stance abuse. Many of these modifiable risk factors have a
genetic basis (obesity, blood pressure, total cholesterol)
or, at a minimum, tend to aggregate in families (smoking,
personality traits). These factors also change over time in
prevalence and potential effect on phenotype (an age-spe-
cific penetrance). By examining age-stratified heritability
associated with common risk factors, a better understand-
ing of the genetic contribution to their phenotypic vari-
ance can be made. In addition, estimation of the
heritability of these factors as surrogates of age-specific
penetrance can be used to test constancy across age
groups.
One approach in better understanding the genetic basis of
CVD is to study the genetic basis of the underlying quan-
titative traits. There are several advantages for studying
quantitative trait phenotypes. These advantages include
1) information from all family members can be used in
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and 2) the strength of genetic control of these phenotypic
determinants (heritability) may be substantial and, there-
fore, more amenable to genetic mapping than the qualita-
tive trait. Narrow-sense heritability (h2) for selected
quantitative trait phenotypes [height, weight, body mass
index (BMI) and systolic blood pressure (SBP)] will be
estimated using a variance component approach [1] in the
Framingham Heart Study (FHS), a longitudinal study of
CVD risk factors.
Methods
The FHS is a longitudinal, community-based study that
also included spouses and offspring of the original FHS
cohort. Data was provided on 330 pedigrees from FHS
consisting of 4692 subjects, in which 2885 had data and
some genetic information. Three age groups were parti-
tioned out at time points 40 (± 9), 55 (± 5), and 70 (± 9)
years. In order to provide a constant cohort size for data
analysis, each subject had to have a "key" phenotype
measured for each time period.
The value associated for each phenotype was taken at the
closest available time point to the three age classes. These
three age groups were chosen to give a broad timeline for
comparison. Given that the majority of the data seemed to
center around the middle age group, we broadened the
outer ranges in an effort to keep a wide enough time frame
between the three different groups. First, the closest time
point around age 55 was selected. Next, data for age
groups 40 and 70 were chosen. Given data at the middle
of the 55 age group, the data point for the age 40 group
would have be chosen as close to 40 as possible. If a par-
ticipant did not have data at age 40, then our attempt was
to take an earlier time point rather than a later one to try
and keep the time groups broad. The same was true for the
age 70 group. We wanted to avoid having data points for
an individual for time points like 49, 55, and 61. We tried
to maintain a minimum of 15 years between each of the
three age groups. If a participant did not have a value for
the three time points, then that individual entered the
analysis with missing data for all three age classes. Height
was considered constant and if a time point had a missing
height, the value that preceded the missing time point was
used. BMI was calculated for only those times that con-
tained weight. Weight, BMI, and SBP were all log-trans-
formed as dependent variables (traits), which better
approximated the distributional assumptions. Untrans-
formed values for weight, BMI, and SBP were used when
entered as covariates. For age-adjusted analysis, time peri-
ods were aligned to be consistent across the cohorts. Age
was not used as a covariate in the age-stratified analyses
because age was the stratifying variable. The correspond-
ing year 12 from entry time point was used (time point 7
in Cohort 1; time point 3 in Cohort 2). This time point
represented the majority of the participants (781 out of
the 795) used in the stratified analyses. By maintaining a
consistent sample group, comparison between the two
(age-stratified and age-adjusted) analyses are more
applicable.
Heritability (h2) estimates were determined using Sequen-
tial Oligogenic Linkage Analysis Routines (SOLAR) [2]. A
family was included in the h2 estimates if it contained at
least one sib pair or one avuncular pair. Significance of the
estimated heritability was determined by likelihood ratio
tests, in which the obtained likelihood of the model with
the additive genetic variance component and covariates
was compared with the obtained likelihood of the model
with the additive genetic variance component, con-
strained to be zero. Relationship pair counts were per-




BMI (log-transformed) had the highest residual heritabil-
ity (h2 = 0.64 ( ± 0.11)) for the model with gender,
smoker, and drinker as covariates in the 40-year age group
(Table 1). The lowest estimated residual heritability for
BMI was h2 = 0.42 ( ± 0.09) for the model containing gen-
der as the only covariate in the 55-year age group. The age-
adjusted analysis performed at year 12 had the highest
residual heritability of h2 = 0.53 ( ± 0.10) in the model
containing gender and height as covariates. The lowest
estimated residual heritability for BMI was h2 = 0.46 ( ±
0.10) for the model containing gender as the only
covariate.
Weight
Weight (log-transformed) had the highest residual herita-
bility (h2 = 0.63 (± 0.09)) for the model with gender,
height, smoker, and drinker as covariates in the 40-year
age group (Table 2). The lowest estimated residual herita-
bility for weight was h2 = 0.44 (± 0.10) for the unadjusted
model in the 55-year age group. The age-adjusted analysis
performed at year 12 had the highest residual heritability
of h2 = 0.52 (± 0.10) in the model containing gender,
height, and smoker as covariates. The lowest estimated
residual heritability for weight was h2 = 0.42 (± 0.10) for
the model containing age as the only covariate.
Height
Height (untransformed) had the highest residual herita-
bility (h2 = 0.88 (± 0.06)) for the model with gender as the
only covariate in all three age groups (Table 3). The lowest
estimated residual heritability for height was h2 = 0.48 (±
0.09) for the unadjusted model in the 70-year age group.
The age-adjusted analysis performed at year 12 had the
highest residual heritability of h2 = 0.90 (± 0.06) in thePage 2 of 6
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Trait: BMI (log)
Covariates h2r ± SE p-value variance due to covariates (%)
Unadjusted
Age Group 40 0.53 ± 0.09 <0.0000001 -
Age Group 55 0.43 ± 0.09 <0.0000006 -
Age Group 70 0.43 ± 0.09 <0.0000003 -
Year 12 (age adjusted) 0.46 ± 0.10 <0.0000007 2
Gender
Age Group 40 0.53 ± 0.09 <0.0000001 2
Age Group 55 0.42 ± 0.09 <0.0000007 2
Age Group 70 0.43 ± 0.09 <0.0000003 0.1
Year 12 (age adjusted) 0.46 ± 0.10 <0.0000004 4
Gender, smoker
Age Group 40 0.60 ± 0.09 <0.0000001 5
Age Group 55 0.51 ± 0.09 <0.0000001 3
Age Group 70 0.51 ± 0.09 <0.0000001 3
Year 12 (age adjusted) 0.53 ± 0.10 <0.0000001 6
Gender, drinker
Age Group 40 0.59 ± 0.11 <0.0000001 3
Age Group 55 0.50 ± 0.11 <0.0000010 2
Age Group 70 0.48 ± 0.11 <0.0000023 0.3
Year 12 (age adjusted) 0.50 ± 0.13 <0.0000204 5
Gender, smoker, drinker
Age Group 40 0.64 ± 0.11 <0.0000001 5
Age Group 55 0.55 ± 0.11 <0.0000001 3
Age Group 70 0.53 ± 0.11 <0.0000002 3
Year 12 (age adjusted) 0.52 ± 0.12 <0.0000035 7
Table 2: Heritability estimates for log transformed weight
Trait: Weight (log)
Covariates h2r ± SE p-value variance due to covariates (%)
Unadjusted
Age Group 40 0.51 ± 0.09 <0.0000001 -
Age Group 55 0.44 ± 0.10 <0.0000009 -
Age Group 70 0.45 ± 0.09 <0.0000001 -
Year 12 (age adjusted) 0.42 ± 0.10 <0.0000051 1
Gender, height
Age Group 40 0.60 ± 0.09 <0.0000001 46
Age Group 55 0.51 ± 0.09 <0.0000001 41
Age Group 70 0.51 ± 0.09 <0.0000001 35
Year 12 (age adjusted) 0.45 ± 0.10 <0.0000008 43
Gender, height, smoker
Age Group 40 0.58 ± 0.11 <0.0000001 44
Age Group 55 0.49 ± 0.11 <0.0000021 40
Age Group 70 0.49 ± 0.11 <0.0000025 33
Year 12 (age adjusted) 0.52 ± 0.10 <0.0000001 44
Gender, height, drinkerPage 3 of 6
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mated residual heritability for height was h2 = 0.52 (±
0.09) for the model containing age as the only covariate.
Systolic Blood Pressure (SBP)
SBP (log-transformed) had the highest residual heritabil-
ity (h2 = 0.39 (± 0.11)) for the model with gender, BMI,
smoker, and drinker as covariates in the 40-year age group
(Table 4). The lowest estimated residual heritability for
SBP was h2 = 0.17 (± 0.09) for the unadjusted model in
the 55-year age group. The age-adjusted analysis per-
formed at year 12 had the highest residual heritability of
h2 = 0.47 (± 0.11) in the model containing gender, BMI,
and drinker as covariates. The lowest estimated residual
heritability for SBP was h2 = 0.38 (± 0.09) for the model
containing age as the covariate.
All models that estimated heritability for BMI, weight, and
height were highly significant for rejecting the null
hypothesis of h2 = 0, with p-values < 0.0000025. For SBP,
8 of the 20 models strongly suggested that the heritability
of SBP was highly significantly different from zero (p <
0.001), with no models not reaching significance (p <
0.034).
Discussion
A long-standing concept in animal and plant genetics is
that, over time, the relative contribution of genes to a phe-
notype decreases. This decrease may be due, in part, to the
accumulation of environmental insults that tends to
increase the total phenotypic variance while maintaining
a constant (additive) genetic variance, resulting in lower
heritability estimates over time. Alternatively, different
sets of genes could be contributing to the variance of a
phenotype over time, resulting in an unpredictable (but
not always decreasing) change in heritability. As this con-
cept has not been thoroughly examined in humans, the
data from the FHS represents an opportunity to test these
hypotheses.
In this application of variance component methods, a
decision was made to enhance the comparability of anal-
yses from different age groups by requiring a participant
to have the phenotypic value in all three age groups. In
this fashion, 795 participants in 170 families were
included in the analyses (Table 5). The resulting family
structure revealed that almost all families were nuclear
with at least one sibling pair. The reduction in sample size
and complexity caused low power to detect even the mod-
Age Group 40 0.63 ± 0.11 <0.0000001 45
Age Group 55 0.53 ± 0.11 <0.0000001 41
Age Group 70 0.52 ± 0.11 <0.0000003 36
Year 12 (age adjusted) 0.48 ± 0.12 <0.0000334 42
Gender, height, smoker, drinker
Age Group 40 0.63 ± 0.09 <0.0000001 31
Age Group 55 0.53 ± 0.09 <0.0000001 29
Age Group 70 0.51 ± 0.09 <0.0000001 21
Year 12 (age adjusted) 0.51 ± 0.12 <0.0000057 44
Table 3: Heritability estimates for height (untransformed)
Trait: Height
Covariates h2r ± SE p-value variance due to covariates (%)
Unadjusted
Age Group 40 0.53 ± 0.09 <0.0000001 -
Age Group 55 0.55 ± 0.09 <0.0000001 -
Age Group 70 0.48 ± 0.09 <0.0000001 -
Year 12 (age adjusted) 0.52 ± 0.09 <0.0000001 <0.1
Gender
Age Group 40 0.88 ± 0.06 <0.0000001 53
Age Group 55 0.88 ± 0.06 <0.0000001 52
Age Group 70 0.88 ± 0.06 <0.0000001 53
Year 12 (age adjusted) 0.90 ± 0.06 <0.0000001 53
Table 2: Heritability estimates for log transformed weight (Continued)Page 4 of 6
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traits analyzed at the three specific age groups, three
exhibited high heritability estimates (>0.60) for some
model — BMI (h2 = 0.64 (± 0.11)), weight (h2 = 0.63 (±
0.11)), and height (h2 = 0.88 (± 0.06)). These estimates
are somewhat higher than reported in previous studies
[4,5]. Of these three, only height showed an increase
using the year 12 analysis (h2 = 0.90 (± 0.06)). The year 12
analysis for BMI and weight fell within the range pre-
sented across the three age groups. SBP showed a larger
heritability estimate (h2 = 0.47 (± 0.11)) in the year 12
analysis than the age-stratified analysis (h2 = 0.39 (±
0.11)) and was closer to the maximum values in other
studies. Overall, the heritability estimates seemed consist-
ent over the age groups and with the year 12 age-adjusted
group because the estimates were within one standard
error of each other with almost all models. Based on these
results, it is still unclear whether doing age-stratified
analysis or age-adjusted analysis fits longitudinal data in a
preferred method.
Table 4: Heritability estimates for log transformed SBP
Trait: SBP (log)
Covariates h2r ± SE p-value variance due to covariates (%)
Unadjusted
Age Group 40 0.27 ± 0.09 <0.0014716 -
Age Group 55 0.17 ± 0.09 <0.0177473 -
Age Group 70 0.21 ± 0.09 <0.0044043 -
Year 12 (age adjusted) 0.38 ± 0.09 <0.0000094 3
Gender, BMI
Age Group 40 0.33 ± 0.10 <0.0001899 13
Age Group 55 0.24 ± 0.09 <0.0035443 12
Age Group 70 0.22 ± 0.09 <0.0033321 4
Year 12 (age adjusted) 0.40 ± 0.09 <0.0000064 9
Gender, BMI, smoker
Age Group 40 0.31 ± 0.10 <0.0010109 15
Age Group 55 0.23 ± 0.10 <0.0059096 11
Age Group 70 0.24 ± 0.09 <0.0024420 4
Year 12 (age adjusted) 0.40 ± 0.10 <0.0000116 7
Gender, BMI, drinker
Age Group 40 0.39 ± 0.11 <0.0002247 15
Age Group 55 0.27 ± 0.11 <0.0054002 12
Age Group 70 0.19 ± 0.10 <0.024959 4
Year 12 (age adjusted) 0.47 ± 0.11 <0.0000076 7
Gender, BMI, smoker, drinker
Age Group 40 0.39 ± 0.12 <0.0002241 15
Age Group 55 0.26 ± 0.11 <0.0069485 12
Age Group 70 0.18 ± 0.11 <0.0324463 4
Year 12 (age adjusted) 0.46 ± 0.11 <0.0000110 7
Table 5: Demographics
Variable Age Group 40 Age Group 55 Age Group 70 Year 12 From Study EntryA
Mean Age (SD, N) 42.5 (3.3, 795) 55.3 (1.0, 795) 68.2 (3.2, 795) 52.5 (5.7, 781)
% Female (N) 55.6 (795) 55.6 (795) 55.6 (795) 55.4 (781)
Mean Height (SD, N) 65.2 (3.8, 792) 65.0 (3.7, 792) 64.3 (3.7, 792) 65.2 (3.7, 778)
Mean Weight (SD, N) 155.4 (29.4, 795) 159.4 (29.9, 795) 160.2 (31.3, 795) 158.6 (30.5, 765)
Mean BMI (SD, N) 25.6 (3.7, 792) 26.4 (3.9, 792) 27.1 (4.4, 792) 26.1 (4.0, 762)
Mean SBP (SD, N) 125.8 (16.2, 795) 131.7 (18.5, 795) 139.9 (20.6, 795) 130.9 (18.2, 768)
% Smoke (N) 54.1 (777) 36.6 (795) 17.2 (793) 40.3 (767)
% Drink (N) 76.2 (740) 71.0 (747) 58.3 (775) 69.2 (768)
AVisit 7 for Cohort 1 and visit 3 for Cohort 2.Page 5 of 6
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